New owner for plant cell production firm
DFB Pharmaceuticals has acquired fellow US company Phyton to gain access to the latter's plant cell fermentation technology for the manufacture of pharmaceuticals.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs